| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 4870 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 15763 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 33947 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 88590 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 100963 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 142341 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 152534 | Peak height | Germ Free Control |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 226703 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 391045 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 697809 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 838269 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 956944 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 960556 | Peak height | Normal Human Infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1061496 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1132440 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1229422 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1307307 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1355828 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1451090 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1569066 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1760669 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1784038 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 1988664 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 2286437 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 2511724 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 3002207 | Peak height | Alcoholic cirrhosis infusion |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 3831884 | Peak height | LGG Treated |
| Reversed phase NEGATIVE ION MODE | FA (18:3) (linolenic acid) | 3925179 | Peak height | Alcoholic cirrhosis infusion |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|